Rash News and Research

RSS
Lung cancer patients taking Tarceva who develop a rash fair better

Lung cancer patients taking Tarceva who develop a rash fair better

Skin rash actually signifies better outcomes for pancreatic and lung cancer patients

Skin rash actually signifies better outcomes for pancreatic and lung cancer patients

Meningococcal vaccine now recommended for ages 11 to 18

Meningococcal vaccine now recommended for ages 11 to 18

New approach for tackling allergies

New approach for tackling allergies

Bayer and Onyx submit supplemental NDA for Nexavar

Bayer and Onyx submit supplemental NDA for Nexavar

Green light for first drug to treat fibromyalgia

Green light for first drug to treat fibromyalgia

U.S. FDA approves Lyrica (pregabalin), the first drug to treat fibromyalgia

U.S. FDA approves Lyrica (pregabalin), the first drug to treat fibromyalgia

Discomfort and disability caused by shingles can be avoided

Discomfort and disability caused by shingles can be avoided

Goltz syndrome gene found

Goltz syndrome gene found

Genzyme files for FDA approval of single-treatment Synvisc-One

Genzyme files for FDA approval of single-treatment Synvisc-One

Summertime is tick time and Lyme disease is on the rise

Summertime is tick time and Lyme disease is on the rise

Lyme disease on the increase in U.S.

Lyme disease on the increase in U.S.

Talcum powder stunts cancer growth

Talcum powder stunts cancer growth

Endocannabinoids appear to play important role in regulating inflammation

Endocannabinoids appear to play important role in regulating inflammation

Axitinib shows promise in treatment of advanced thyroid cancer

Axitinib shows promise in treatment of advanced thyroid cancer

Results of phase II studies of pazopanib

Results of phase II studies of pazopanib

FDA approves Torisel (temsirolimus) for advanced kidney cancer

FDA approves Torisel (temsirolimus) for advanced kidney cancer

Temsirolimus, effective new treatment for advanced renal cell carcinoma

Temsirolimus, effective new treatment for advanced renal cell carcinoma

Guidelines on skin reactions to Epidermal Growth Factor Receptor Inhibitors (EGFRIs)

Guidelines on skin reactions to Epidermal Growth Factor Receptor Inhibitors (EGFRIs)

New treatment for toxic shock syndrome

New treatment for toxic shock syndrome